New study aims to sharpen brain tumor monitoring with PET imaging
NCT ID NCT07159607
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study will follow 100 adults with IDH-mutant gliomas (a type of brain tumor) to see if special PET scans can better detect tumor growth or treatment side effects compared to standard MRI. Researchers will collect PET images taken during routine care and compare them with patient outcomes like survival. The goal is to improve future guidelines for monitoring these tumors.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this study could improve how doctors use PET scans to tell if a brain tumor is growing or just reacting to treatment, leading to better monitoring guidelines.
- What could go wrong
- This is an observational study, not a treatment trial, so it won't directly help patients. Results may not change practice if the PET findings don't clearly link to outcomes.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for IDH-MUTANT GLIOMA (OLIGODENDROGLIOMA, ASTROCYTOMA) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
LMU Hospital
RECRUITINGMunich, Bavaria, 81377, Germany
-
Medical University of Vienna
RECRUITINGVienna, 1090, Austria
More trials for these conditions
Other studies related to the condition(s) this trial covers.